Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: A randomized, placebo-controlled, double-blind, double-dummy study

International Archives of Allergy and Immunology

Volumn 157, Issue 3, 2012, Pages 288-298

  Yukselen, Ayfer ^a   Kendirli, Seval Güneser ^b   Yilmaz, Mustafa ^b   Altintas, Derya Ufuk ^b   Karakoc, Gulbin Bingol ^b  

^a Clinic of Pediatric Allergy and Immunology   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Asthma; Children; Rhinitis; Subcutaneous immunotherapy; Sublingual immunotherapy

Indexed keywords

ALLERGEN; BUDESONIDE; GAMMA INTERFERON; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 10; MOMETASONE FUROATE; NOVOHELISEN DEPOT; NOVOHELISEN ORAL; PLACEBO; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; EOSINOPHIL; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FUNCTION TEST; MALE; MOUTH EDEMA; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SPUTUM; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; SYMPTOM; THROAT DISEASE; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ALLERGENS; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHIAL PROVOCATION TESTS; CHILD; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; INTERLEUKIN-10; MALE; NASAL PROVOCATION TESTS; RHINITIS; TREATMENT OUTCOME;

EID: 80055002825     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000327566     Document Type: Article

References (47)

1. Malling HJ, Weeke B: EAACI position paper. Immunotherapy. Allergy 1993; 48(suppl 14):7-35.
2. Bousquet J, Lockey R, Malling HJ: WHO position paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. J Allergy Clin Immunol 1998; 102: 558-562.
3. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J: Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 1997; 99: 450-453. (Pubitemid 27173080)
4. Jacobsen L, Nuchel Petersen B, Wihl JA, Løwenstein H, Ipsen H: Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy 1997; 52: 914-920. (Pubitemid 27375009)
5. Möller C, Dreborg S, Ferdousi HA, Halken S, Høst A, Jacobsen L, Koivikko A, Koller DY, Niggemann B, Norberg LA, Urbanek R, Valovirta E, Wahn U: Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT Study). J Allergy Clin Immunol 2002; 109: 251-256. (Pubitemid 34158289)
6. Sabbah A, Hassoun S, Le Sellin J, André C, Sicard H: A double-blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994; 49: 309-313. (Pubitemid 24163858)
7. Clavel R, Bousquet J, André C: Clinical efficacy of sublingual-swallow immunotherapy: A double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998; 53: 493-498. (Pubitemid 28248417)
8. Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F: Sublingual versus injective immunotherapy in grass pollen allergic patients: A double blind (double dummy) study. Clin Exp Allergy 1996; 26: 1253-1261. (Pubitemid 26388998)
9. Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS, Canonica GW: Randomized controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998; 351: 629-632. (Pubitemid 28098445)
10. Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, André C, Papageorgiou PS: Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998; 53: 662-672. (Pubitemid 28319999)
11. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB, Pauli G, Caillaud D, Dubost R, Leynadier F, Vervloet D, Herman D, Galvain S, André C: Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: A double-blind, placebo-controlled study. Allergy 1999; 54: 249-260. (Pubitemid 29185286)
12. Canonica GW, Passalacqua G: Noninjection routes for immunotherapy. J Allergy Clin Immunol 2003; 111: 437-448, quiz 449. (Pubitemid 36337857)
13. Ameal A, Vega-Chicote JM, Fernandez S, Miranda A, Carmona MJ, Rondón MC, Reina E, García-González JJ: Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma. Allergy 2005; 60: 1178-1183. (Pubitemid 41153147)
14. Varney VA, Tabbah K, Mavroleon G, Frew AJ: Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: A double blind, randomized, placebo-controlled trial. Clin Exp Allergy 2003; 33: 1076-1082. (Pubitemid 36976234)
15. Pichler CE, Marquardsen A, Sparholt S, Løwenstein H, Bircher A, Bischof M, Pichler WJ: Specific immunotherapy with Dermatophagoides pteronyssinus and Dermatophagoides farinea results in decreased bronchial hyperreactivity. Allergy 1997; 52: 274-283. (Pubitemid 27166228)
16. Pichler CE, Helbling A, Pichler WJ: Three years of specific immunotherapy with house dust mite extracts in patients with rhinitis and asthma: Significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy 2001; 56: 301-306. (Pubitemid 32222609)
17. Hirsch T, Sahn M, Leupold W: Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children. Pediatr Allergy Immunol 1997; 8: 21-27. (Pubitemid 27365651)
18. Mungan D, Misirligil Z, Gurbuz L: Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma -a placebo-controlled study. Ann Allergy Asthma Immunol 1999; 82: 485-490. (Pubitemid 29242317)
19. Guez S, Vatrinet C, Fadel R, André C: House dust mite sublingual swallow immunotherapy (SLIT) in perennial rhinitis: A doubleblind, placebo-controlled study. Allergy 2000; 55: 369-375.
20. Pajno GB, Morabito L, Barberio G, Parmiani S: Clinical and immunologic effects of long term sublingual immunotherapy in asthmatic children sensitized to mites: A doubleblind, placebo-controlled study. Allergy 2000; 55: 842-849. (Pubitemid 30643909)
21. Bahceciler NN, Isik U, Barlan IB, Basaran MM: Efficacy of sublingual immunotherapy in children with asthma and rhinitis: A double-blind, placebo-controlled study. Pediatr Pulmonol 2001; 32: 49-55.
22. Olaguibel JM, Alvarez Puebla MJ: Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusion from one-meta-analysis. J Investig Allergol Clin Immunol 2005; 15: 9-16. (Pubitemid 40547626)
23. Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, Canonica GW: Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: A metaanalysis of randomized, placebo-controlled double-blind trials. Ann Allergy Asthma Immunol 2006; 97: 141-148. (Pubitemid 44272577)
24. Compalati E, Passalacqua G, Bonini M, Canonica GW: The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: Results of a GA2LEN meta-analysis. Allergy 2009; 64: 1570-1579.
25. Bousquet J, Van Cauwenberge P, Khaltaev N, ARIA Workshop Group (World Health Organization): Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(suppl 5):S147-S334.
26. Wahn U, Tabar A, Kuna P, Halken S, Montagut A, de Beaumont O, Le Gall M, SLIT Study Group: Efficacy and safety of 5-grasspollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol 2009; 123: 160-166.
27. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention: NHLBI/WHO Workshop Report, publication No. 95-3659. Bethesda, National Institute of Health and National Heart, Lung and Blood Institute, 1995.
28. EAACI Subcommittee: Provocation tests with allergens. Allergy 1997; 52(suppl 35):5-36.
29. Gosepath J, Amedee RG, Mann WJ: Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. Laryngoscope 2005; 115: 512-516. (Pubitemid 40328003)
30. Inal A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB, Erdogan S: Indices of lower airway inflammation in children monosensitized to house dust mite after nasal allergen challenge. Allergy 2008; 63: 1345-1351.
31. Melillo G, Aas K, Cartier A, Davies RJ, Debelic M, Dreborg S, Kerrebijn KF, Lassen A, Pinto Mendes J, Rizzo A, et al: Guidelines for the standardization of bronchial provocation tests with allergens: An update by international committee. Allergy 1991; 46: 321-329.
32. International Workshop Report: Dust mite allergens and asthma: A worldwide problem. Bull World Health Organ 1988; 66: 769-780.
33. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S: Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007; 1:CD001936.
34. Passalacqua G, Durham SR: Allergic rhinitis and its impact on asthma update: Allergen immunotherapy. J Allergy Clin Immunol 2007; 119: 881-891. (Pubitemid 46527840)
35. Abramson MJ, Puy RM, Weiner JM: Allergen immunotherapy for asthma. Cochrane Database Syst Rev 2003; 4:CD001186.
36. Malling HJ: Immunotherapy as an effective tool in allergy treatment. Allergy 1998; 53: 461-472.
37. Abramson M, Puy R, Weiner J: Immunotherapy in asthma: An updated systematic review. Allergy 1999; 54: 1022-1041. (Pubitemid 29482002)
38. Ross RN, Nelson HS, Finegold I: Effectiveness of specific immunotherapy in the treatment of asthma: A meta-analysis of prospective, randomized, double-blind, placebocontrolled studies. Clin Ther 2000; 22: 329-341. (Pubitemid 30213139)
39. Calamita Z, Saconato H, Pela AB, Atallah AN: Efficacy of sublingual immunotherapy in asthma: Systematic review of randomizedclinical trials using the Cochrane collaboration method. Allergy 2006; 61: 1162-1172. (Pubitemid 44326350)
40. Pham-Thi N, de Blic J, Scheinmann P: Sublingual immunotherapy in the treatment of children. Allergy 2006; 61(suppl 81):7-10.
41. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A, Canonica GW: Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008; 133: 599-609. (Pubitemid 351367366)
42. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR: Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trial. J Allergy Clin Immunol 2001; 107: 87-93. (Pubitemid 32105250)
43. Martínez-Cócera C, Sastre J, Cimarra M, Quirce S, Fernández-Rivas M, Enríquez-Matas A, Rodríguez-Alvarez M, Martín S: Immunotherapy with a Phleum pratense allergen extract induces an immune response to a grass-mix allergen extract. J Investig Allergol Clin Immunol 2010; 20: 13-19.
44. Ciprandi G, De Amici M, Tosca MA, Pistorio A, Marseglia GL: Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis. Int J Immunopathol Pharmacol 2009; 22: 1089-1096.
45. Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E: Sublingual immunotherapy with Dermatophagoides monomeric allergoid downregulates allergen-specific immunoglobulin E and increases both interferon-gamma-and interleukin-10-production. Clin Exp Allergy 2006; 36: 261-272. (Pubitemid 43344707)
46. Khinchi MS, Poulsen LK, Carat F, Andre C, Hansen AB, Malling HJ: Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: A randomized, placebo-controlled, double-blind, double-dummy study. Allergy 2004; 59: 45-53. (Pubitemid 38167951)
47. Eifan AO, Akkoc T, Yildiz A, Keles S, Bahceciler NN, Barlan IB: Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/ rhinitis children sensitized to house dust mite: An open randomized controlled trial. Clin Exp Allergy 2010; 40: 922-932.